Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

Primo Biotechnology

Primo aims at precision medicine and help the development of radioligand theranostics (RLT).
2023
11-50
Taipei, T’ai-pei, Taiwan
BiotechnologynologyPharmaceuticalsPrecision Medicine

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

14.03M

Last Funding Amount

7.53M

Last Funding Date

02-07-2025

Startup Stage

Early Stage

Lead Investors

AVA Angels

Revenue

$1M to $10M